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Abstract
The work describes the physical basis of the chemical exchange saturation transfer (CEST) technique; it presents 
the beginnings of the implementation of the method and its possible applications. The principles of correct data 
acquisition and possible solutions used during the design of the CEST sequence are shown. The main problems 
related to data analysis are indicated, and an example Z-spectrum from in vivo study of the rat brain is introduced. 
Furthermore, the parameters related to spectrum analyses such as magnetisation transfer asymmetry (MTRasym) 
and amide proton transfer asymmetry (APTasym) are presented. In the following part, different types of the CEST 
method often mentioned in the literature are discussed. Subsequently, the possible applications of the CEST method 
in both clinical and experimental practice are described.
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Introduction
Magnetic resonance imaging techniques have constantly 
been developing in recent years. Researchers’ efforts are di-
rected towards shortening the time of sequences, improv-
ing the resolution, and thus obtaining the most detailed 
images. Also, metabolic imaging such as magnetic reso-
nance spectroscopy (MRS) has become the focus of many 
clinical and research centres. The information obtained 
during the spectroscopic study relates to the metabolic 
composition of tissues. Depending on the region of inter-
est chosen, the study may refer to the observation of the 
metabolism of healthy tissues or those altered by disease. 
The main advantage of MRS is its relato be quite a high 
detection threshold (around 1 mM). To meet these limita-
tions a new method of metabolic imaging named chemical 
exchange saturation transfer (CEST) has emerged. Initially 
it was mentioned referring only to the proton exchange 
process as early as in 1951 by Arnold and Liddel [1,2]. 
In 2000, for the first time named CEST, the method was 
shown by Ward and Balaban [3,4] as an alternative for 
known paramagnetic contrast agents. Since then it has 
become more popular and has been increasingly used in 
recent years. The aim of this work is to explain the phys-
ical basis of the CEST technique and to describe possible 
applications in clinical and research projects. 
The basis of CEST technique
CEST is based on the phenomenon of chemical exchange 
between solute and water protons. Temporarily connect-
ed to the different chemical compounds, protons are 
constantly migrating and merging with water molecules. 
The speed of this process is determined by the parameter 
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and readout gradient involvement (Figure 2). During satu-
ration labelled protons are continuously transferred to the 
bulk water pool leading to a build-up of water signal loss. 
Pulses are tuned to the range of the frequency offsets 
from +Δω to –Δω from the water with the amplitude of 
B1 and duration time tsat (which should be much longer 
than T1). Over one acquisition only one frequency offset 
is required, so the scheme is repeated until the entire fre-
quency spectrum is achieved [7,8]. 
Data interpretation
The interpretation of the CEST spectrum, called also the 
Z-spectrum or Z-spectroscopy [9], is complicated and 
presents many problems related not only to the need of 
understanding the physics of the phenomenon but also 
with the preservation of appropriately selected parameters 
of sequence acquisition. The main factors that may affect 
data interpretation are: field strength, B1 inhomogeneity 
[10-14], radio frequency (RF) pulse power optimisation 
[15], pH and temperature drift, the presence of magnetisa-
tion transfer effect [16], water direct saturation effect, and 
relaxation times [17,18]. For this reason, the acquisition 
is not limited to only one sequence during which data is 
collected to obtain the Z-spectrum. Typically, the protocol 
contains additional sequences such as magnetisation trans-
fer (MT), water saturation shift referencing (WASSR), and 
one for T1 relaxation time measurement [19]. 
Most of the compounds analysed in the CEST exper-
iment are located on the left side of the graph marked as 
positive frequencies in relation to water, while the right 
side mainly originates from the nuclear Overhauser effect 
(NOE) aliphatic compounds and lipids [20]. In contrast 
to the MRS spectrum in CEST plot 0 ppm frequency in-
dicates the maximum water saturation point. 
Figure 3 presents an example Z-spectrum obtained 
from in vivo study of rat brain (region of interest marked 
in Figure 4) after manual segmentation of hippocampus. 
Data were processed with B0 shift adjustment, B1 scale, 
and baseline correction. 
During the CEST analysis, one of the most important 
parameters, which is often calculated, is the magnetic 
transfer ratio asymmetry (MTRasym), sometimes called 
CEST asymmetry (CESTasym). It is expressed by the fol-
lowing formula: 
MTRasym(Dw) = 
S(–Dw) – S (Dw)
S0
where (Dw) is analysed frequency offset, S(–Dw) and 
S(–Dw) refer to signal intensity at the positive and the 
negative side of the Z-spectrum, and S0 is the signal in-
tensity without saturation. MTRasym measurement analysis 
provides information about the CEST contrast scale. One 
particular CEST peak, which is located at 3.5 ppm, refers 
to compounds which contain i.a. amide groups. This offset 
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characteristic for each compound, called the exchange 
rate ksw (between two pools) [5]. The smaller pool con-
tains exchangeable protons, and the larger pool reflects 
bulk water protons (Figure 1).
Exchangeable protons, due to the chemical environ-
ment, resonate in frequencies that are shifted with respect 
to the resonant frequency of water. During signal acquisi-
tion saturation pulses are transmitted at a frequency range 
that corresponds to chemical shifts of particular com-
pounds. Respectively, saturation is transferred from the 
solute protons to the protons of the water, which results 
in attenuation of the total water signal. This signal loss is 
therefore proportional to the amount of compound with 
exchangeable protons. This gives an opportunity to indi-
rectly measure the concentration of metabolites found in 
the tissue even at very small concentrations, in the order 
of µM or even less in LipoCEST [6]. 
Data acquisition
There are several known schemes for the construction of 
the CEST sequence. Their type depends on the pattern 
of saturation impulses used. The most popular ones are 
those with rectangular, continuous wave saturation pulses. 
A magnetisation transfer prepared sequence starts with the 
saturation impulse followed by excitation, spatial encoding, 
N
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is related to amide proton transfer (APT), so asymmetry 
of this peak is also termed amide proton transfer asym-
metry (APTasym) [21,22].
Different types of CEST
The CEST technique is often presented as an alternative 
way of obtaining the signal from molecules that have not 
been visible in known MR molecular imaging methods. 
Several major types of this method are described in the 
literature, and each of them enables imaging of very dif-
ferent types of compounds. The most popular types of 
CEST are described below.
DiaCEST requires the use of long saturation pulses of 
relatively small B1 power amplitudes. It allows the signal 
from molecules to be obtained, whichare in the frequency 
range of 0 ppm to +7 ppm from the water [9,23]. Most of 
them are compounds that may be found in the tissues. 
Some of them are important markers of pathological or 
physiological processes. These molecules contain mostly 
amide, amine, hydroxyl, and imino groups. The interpre-
tation of the Z-spectrum originating from living tissues 
may be difficult due to a possible, hard to distinguish 
overlap of CEST effects of separate metabolites. Therefore, 
a lot of research is being done with the use of phantoms 
for a better understanding of the nature of this phenome-
non [24-27]. Exemplary spectra of single metabolites are 
shown in Figure 5. 
ParaCEST is another type of CEST, which refers to 
a group of exogenous compounds with weak magnetic 
properties that are characterised by high exchange rates 
and large chemical shifts in relation to water. Many of 
them have been proposed as an alternative to tradition-
al gadolinium-based contrast agents, e.g. Mn2+, Eu3+, or 
Figure 3. In vivo Z-spectrum of rat hippocampus – compounds in the range of +6 ppm to –6 ppm from the water resonant frequency. Source: Spectrum 
obtained from CEST sequence, 7 T Bruker PharmaScan, animal system, Centre of Experimental Medicine, Medical University of Lublin
Figure 4. The region of interest of in vivo Z-spectrum analysis – manu-
ally segmented rat hippocampus. Source: T2-weighted RARE image from 
7 T Bruker PharmaScan, animal system, Centre of Experimental Medicine, 
Medical University of Lublin
Ln3+ complexes. They can also include hydroxyl, amide, 
or amine groups, and may be connected with molecules of 
bound water. ParaCEST can be used to detect the metabo-
lites or the presence of nucleic acids and some ions [28,29]. 
In LipoCEST the spherical liposome is filled with 
a compound of high concentration (paramagnetic shift 
reagent), which changes by quick exchange the resonant 
frequency of water trapped in the liposome. Water in 
a confined space is shifted by about 4 ppm downfield to 
bulk water. The exchange of water inside the liposome 
with external water takes place slowly, which gives good 
conditions for Z-spectrum detection. Such a spectrum 
contains two peaks of water at a short distance from each 
other. Compounds that are paramagnetic shift reagents 
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must have at least one water molecule that is able to ex-
change fast [30-32].
HyperCEST – this type of CEST does not rely on the 
proton exchange, as do the types presented so far, but on 
the exchange between whole molecules. Hyperpolarised 
atoms of xenon (129Xe) are visible in the spectrum in two 
different states: as free molecules and as molecules caged 
in host compound, like cryptophane [33,34]. They have 
different resonant frequencies, distant from each other by 
approximately 100 ppm, which results in good peak sepa-
ration. During saturation of free atoms on their frequency 
offset magnetisation transfer is moved to the atoms asso-
ciated with the host, which results in its signal loss, which 
is dependent on the amount of compound in the tissue. 
It is also worth mentioning that HyperCEST is very sensi-
tive even for small temperature changes [35]. 
Possible CEST applications
There are several studies that have described application 
of the CEST method in imaging of pathologies of the 
nervous system, focused mainly on multiple sclerosis in 
the brain and spinal cord [14,36-38] and an animal model 
of Alzheimer’s disease [39]. This study presented a differ-
ence in the concentration of amide protons by ATPasym 
analysis in healthy tissues compared to those altered by 
disease. Also, gluCEST, which is based on a signal from 
glutamate and shows a CEST peak at 3.0 pmm, has been 
used in the diagnosis of epilepsy and neuroinflammation 
[40,41].
 Another field of application for CEST method is 
oncology. Studies conducted in field 3 T show the pos-
sibility of distinguishing tumour progression from radi-
ation necrosis in a study of patients with metastases af-
ter stereotactic surgery. Analysis of asymmetry in amide 
(MTR3.5ppm_necrosis = 8.2 ±1.0% and MTR3.5ppm_progression = 12.0 ± 
1.9%, p = 0.0002) and NOE (NOE3.5ppm_necrosis = 8.8 ± 0.9% 
and NOE3.5ppm_progression = 12.7 ±1.16%, p = 0.0001) peaks 
delivered statistically significantly different results in dif-
ferent groups [42]. In a contrary examination in 9.4 T did 
not produce results that differ significantly in ATPasym in 
tumour and in normal tissue; only the NOE effect was 
decreased suggestively in tumours [43]. 
D-glucose is widely used in positron emission tomog-
raphy (PET). However, its visualisation requires the use 
of a radiotracer not indifferent to health. CEST gives the 
opportunity to observe the glucose metabolism without 
additional exposure to radiation. MRI of glucoCEST 
showed strong uptake of glucose in tumours of head and 
neck and also a visible correlation of these results with 
PET studies [44,45].
The creatine CEST effect is detectable at around 2.0 ppm 
[46], which proved important in the imaging of muscle 
physiology. To show the importance of filed strength in 
CEST effect visualisation the same study was performed 
in 3 and 7 T magnetisation in a range of saturation power 
of 1.75-2.9 µT. During that examination the patient was 
obliged to perform a simple physical exercise (pressing 
on a pedal). The acquisition was done before and after the 
exercise. The results revealed an increased creatine signal 
in medial and lateral gastrocnemius muscles after physical 
effort [47,48]. 
New directions of using the CEST effect are constantly 
appearing. One of them was obtainment of Z-spectrum 
from human blood in 7 T from in vivo and in vitro sam-
ples. The authors suggest that the results of their research 
should be taken into consideration in the case of under-
standing pathologies in which changes in vascular volume 
occur [49].
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Figure 5. Z-spectrum of two phantoms containing separate metabolites and their dependency on saturation pulse power: A) 100 mM of creatine dissolved 
in water; B) 100 mM of glutamine dissolved in water. Source: Data obtained from the phantom study, 7 T Bruker PharmaScan, animal system, Centre of 
Experimental Medicine, Medical University of Lublin
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Conclusions
CEST is a promising molecular imaging tool, which pro-
vides new opportunities for researchers and clinicians. It al-
lows the imaging of signals from chemical compounds that 
cannot be captured in known classical imaging methods, 
even in a millimolar scale. Despite many technical difficul-
ties in obtaining correct data, the method finds many appli-
cations in various fields of medicine. CEST method investi-
gators are still developing this method to overcome known 
limitations and to provide some standards for clinical use. 
The CEST method is mainly used in imaging metabol-
ic markers of neurological disorders, but it is also applica-
ble in oncology and in a demonstration of pathology and 
physiology of the musculoskeletal system. 
In conclusion, CEST has great potential to be exten-
sively explored. Thus, in the coming years, there is a high 
probability of an increase of interest and extension of pos-
sible applications of this method. 
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